Therapeutic Peptides intermediate
Peptide Renal Therapeutics
Therapeutic peptides for kidney diseases including erythropoiesis-stimulating agents and phosphate binders.
By Encyclopeptide Editorial | 1 min read
renal therapeutic erythropoietin kidney-disease nephrology
Overview
Peptides play crucial roles in nephrology, from treating anemia of chronic kidney disease to managing mineral and bone disorders.
Major Renal Peptides
| Drug | Indication | Mechanism |
|---|---|---|
| Epoetin alfa | CKD anemia | Erythropoiesis |
| Darbepoetin alfa | CKD anemia | Erythropoiesis |
| Paricalcitol | CKD-MBD | VDR activation |
Clinical Applications
- Anemia of chronic kidney disease
- CKD-mineral bone disorder
- Hyperphosphatemia
- Renal osteodystrophy
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Renal Therapeutics |
| Category | Therapeutic Peptides |
References
- Encyclopeptide Database. “Peptide Renal Therapeutics” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Renal Therapeutics with interactive quizzes on Wikipept.
Take a Quiz on Wikipept